Sign In
Buy BOLT
$4.63
-0.480 (-9.39%)
At Close: Jun 03, 2026
BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:10am, Tuesday, 13'th Aug 2024
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. (“Bo
NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ:BOLT) and certain
NEW YORK CITY, NY / ACCESSWIRE / August 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biot
Investors Are Invited To Lead The Securities Fraud Lawsuit Of Bolt Biotherapeutics Inc With The Schall Law Firm
09:15pm, Monday, 12'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violation
NEW YORK CITY, NY / ACCESSWIRE / August 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biot
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ:BOLT) and certain
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Contact the Firm!
10:00am, Sunday, 11'th Aug 2024
NEW YORK CITY, NY / ACCESSWIRE / August 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biot
Investors Can Head The Securities Fraud Lawsuit Of Bolt Biotherapeutics Inc With The Schall Law Firm
10:00pm, Friday, 09'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bol
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 20
NEW YORK CITY, NY / ACCESSWIRE / August 9, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Bioth
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT) and certain offic
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
05:45pm, Thursday, 08'th Aug 2024
NEW YORK , Aug. 8, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021
Investors Have The Opportunity To Lead Bolt Biotherapeutics Inc Securities Fraud Lawsuit With The Schall Law Firm
04:45pm, Thursday, 08'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bol
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Lead Class Action Lawsuit!
10:00am, Thursday, 08'th Aug 2024
NEW YORK CITY, NY / ACCESSWIRE / August 8, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Bioth
BOLT Investors Are Invited To Take The Lead In The Bolt Biotherapeutics Inc Securities Fraud Case With The Schall Law Firm
09:15pm, Wednesday, 07'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bol
